Wąsik-Szczepanek E - Search Results

1

Examination of clonal evolution in chronic lymphocytic leukemia.

Koczkodaj D, Popek-Marciniec S, Zmorzyński S, Wąsik-Szczepanek E, Filip AA. Koczkodaj D, et al. Med Oncol. 2019 Aug 2;36(9):79. doi: 10.1007/s12032-019-1300-2. Med Oncol. 2019. PMID: 31375939

2

[Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part I. B-cell lymphocytic leukemia with TP53 gene deletion].

Koczkodaj D, Rupniewska ZM, Wasik-Szczepanek E, Bojarska-Junak A. Koczkodaj D, et al. Pol Arch Med Wewn. 2003 Dec;110(6):1395-403. Pol Arch Med Wewn. 2003. PMID: 15052934 Polish.

3

[Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part II. Trisomy 12 in B-cell chronic lymphocytic leukemia detected by fluorescence in situ hybridization].

Wasik-Szczepanek E, Rupniewska ZM, Koczkodaj D, Bojarska A. Wasik-Szczepanek E, et al. Pol Arch Med Wewn. 2003 Dec;110(6):1431-8. Pol Arch Med Wewn. 2003. PMID: 15052938 Polish.

4

The clinical significance of ZAP-70 and CD38 expression in B-cell chronic lymphocytic leukaemia.

Hus I, Podhorecka M, Bojarska-Junak A, Roliński J, Schmitt M, Sieklucka M, Wasik-Szczepanek E, Dmoszyńska A. Hus I, et al. Ann Oncol. 2006 Apr;17(4):683-90. doi: 10.1093/annonc/mdj120. Epub 2006 Mar 8. Ann Oncol. 2006. PMID: 16524977 Free article.

5

ZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive value.

Hus I, Bojarska-Junak A, Dmoszyńska A, Wasik-Szczepanek E, Sieklucka M, Trześniewska W, Glazer M, Roliński J. Hus I, et al. Folia Histochem Cytobiol. 2008;46(2):147-52. doi: 10.2478/v10042-008-0022-7. Folia Histochem Cytobiol. 2008. PMID: 18519230 Free article.

6

BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features.

Bojarska-Junak A, Hus I, Chocholska S, Wasik-Szczepanek E, Sieklucka M, Dmoszyńska A, Roliński J. Bojarska-Junak A, et al. Leuk Res. 2009 Oct;33(10):1319-27. doi: 10.1016/j.leukres.2009.03.030. Epub 2009 Apr 23. Leuk Res. 2009. PMID: 19395025

7

Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.

Giannopoulos K, Dmoszynska A, Kowal M, Wasik-Szczepanek E, Bojarska-Junak A, Rolinski J, Döhner H, Stilgenbauer S, Bullinger L. Giannopoulos K, et al. Leukemia. 2009 Oct;23(10):1771-8. doi: 10.1038/leu.2009.98. Epub 2009 May 14. Leukemia. 2009. PMID: 19440214

8

Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome.

Bojarska-Junak A, Hus I, Sieklucka M, Wasik-Szczepanek E, Mazurkiewicz T, Polak P, Dmoszynska A, Rolinski J. Bojarska-Junak A, et al. Oncol Rep. 2010 Sep;24(3):803-10. doi: 10.3892/or_00000924. Oncol Rep. 2010. PMID: 20664990

9

Circulating microenvironment of CLL: are nurse-like cells related to tumor-associated macrophages?

Filip AA, Ciseł B, Koczkodaj D, Wąsik-Szczepanek E, Piersiak T, Dmoszyńska A. Filip AA, et al. Blood Cells Mol Dis. 2013 Apr;50(4):263-70. doi: 10.1016/j.bcmd.2012.12.003. Epub 2013 Jan 11. Blood Cells Mol Dis. 2013. PMID: 23313631

10

Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.

Filip AA, Ciseł B, Wąsik-Szczepanek E. Filip AA, et al. Clin Exp Med. 2015 Feb;15(1):73-83. doi: 10.1007/s10238-013-0268-z. Epub 2013 Dec 12. Clin Exp Med. 2015. PMID: 24337970 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters